Stem Cell Theranostics secures “freedom to operate” in IP deal with GE … – BioPharma-Reporter.com
|
Stem Cell Theranostics secures "freedom to operate" in IP deal with GE …
BioPharma-Reporter.com Stem Cell Theranostics announced the sub-license with GE Healthcare last night, explaining that the agreement covers intellectual property (IP) needed to generate human cardiomyocyte models for preclinical drug development from induced pluripotent stem … |
